Perjeta Approval Is A Post-Marketing Affair For FDA, Genentech
The company will establish a pregnancy registry and has committed to conduct a variety of manufacturing studies following pertuzumab’s approval for breast cancer.
The company will establish a pregnancy registry and has committed to conduct a variety of manufacturing studies following pertuzumab’s approval for breast cancer.